IN2015KN00091A - - Google Patents

Info

Publication number
IN2015KN00091A
IN2015KN00091A IN91KON2015A IN2015KN00091A IN 2015KN00091 A IN2015KN00091 A IN 2015KN00091A IN 91KON2015 A IN91KON2015 A IN 91KON2015A IN 2015KN00091 A IN2015KN00091 A IN 2015KN00091A
Authority
IN
India
Prior art keywords
tissue
dehydrated
humans
animals
treatment
Prior art date
Application number
Other languages
English (en)
Inventor
Carlo Terruzzi
Luca Degrassi
Original Assignee
Giellepi S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giellepi S P A filed Critical Giellepi S P A
Publication of IN2015KN00091A publication Critical patent/IN2015KN00091A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Virology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN91KON2015 2012-06-20 2013-06-20 IN2015KN00091A (cs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001076A ITMI20121076A1 (it) 2012-06-20 2012-06-20 Composizione per uso locale nel trattamento del danno tissutale
PCT/IB2013/055066 WO2013190496A2 (en) 2012-06-20 2013-06-20 Composition and formulation for topical treatment of inflammation and tissue damage

Publications (1)

Publication Number Publication Date
IN2015KN00091A true IN2015KN00091A (cs) 2015-07-31

Family

ID=46466706

Family Applications (1)

Application Number Title Priority Date Filing Date
IN91KON2015 IN2015KN00091A (cs) 2012-06-20 2013-06-20

Country Status (8)

Country Link
US (1) US20150320838A1 (cs)
EP (1) EP2863928A2 (cs)
JP (1) JP2015520223A (cs)
CN (1) CN104640552A (cs)
IN (1) IN2015KN00091A (cs)
IT (1) ITMI20121076A1 (cs)
RU (1) RU2015101485A (cs)
WO (1) WO2013190496A2 (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101979358B1 (ko) * 2017-01-03 2019-05-15 서울대학교산학협력단 소 유방염 치료제 조성물

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5897880A (en) * 1995-09-29 1999-04-27 Lam Pharmaceuticals, Llc. Topical drug preparations
KR20000004990A (ko) 1996-03-26 2000-01-25 마크 제이. 건더슨 알의 항염증성 조성물, 그의 단리 방법 및용도
WO2000043019A2 (en) * 1999-01-19 2000-07-27 Dcv Inc Egg anti-inflammatory composition and method of treating and preventing inflammation
JP5047431B2 (ja) * 1999-09-14 2012-10-10 アルキオン ライフ サイエンシズ リミテッド ライアビリティ カンパニー 炎症を低減させるグルコサミンおよび卵
US6706267B1 (en) * 1999-09-14 2004-03-16 Arkion Life Sciences Llc Glucosamine and egg for reducing inflammation
WO2001089540A1 (en) * 2000-05-23 2001-11-29 N.V. Nutricia Use of egg white and egg white fractions for tissue regeneration
FR2810550B1 (fr) 2000-06-27 2004-10-08 Medibrevex Nouvelle formes galeiques solubles d'oeufs de caille a usage medicamenteux pour lavage oculaire et nasale et leurs procedes de fabrication
RU2191551C1 (ru) 2001-07-05 2002-10-27 Волков Александр Григорьевич Способ лечения неосложненных фронтитов
JP5184726B2 (ja) * 2001-10-16 2013-04-17 帝國製薬株式会社 グルコサミン含有パップ剤
US20030125303A1 (en) * 2001-12-28 2003-07-03 Andrew Kucharchuk Transdermal formulation for repair and maintenance of connective tissue
IL148292A (en) * 2002-02-21 2008-08-07 Shai Yarkoni Stable preparations of lupoginone and other quinazolinone derivatives
JP4256125B2 (ja) * 2002-08-05 2009-04-22 ロート製薬株式会社 外用組成物
US20050053564A1 (en) * 2003-09-04 2005-03-10 Chaim Lieberman Use a plant extract to enhance hair growth and hair restoration for damaged hair
WO2005097069A1 (en) * 2004-03-26 2005-10-20 Stiefel Laboratories, Inc. Topical skin protectant cosmetic compositions
US20060110415A1 (en) * 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
EP2094277A4 (en) * 2006-10-20 2010-01-20 Kim Soo Youl COMPOSITION FOR THE TREATMENT OF ATOPIC DERMATITIS WITH GLUCOSAMINE AND ITS DERIVATIVES AND METHOD FOR THE TREATMENT OF ATOPIC DERMATITIS THEREWITH
JP5158436B2 (ja) * 2008-09-18 2013-03-06 国立大学法人 鹿児島大学 抗菌剤およびその製造方法、化粧料ならびに医薬品

Also Published As

Publication number Publication date
US20150320838A1 (en) 2015-11-12
RU2015101485A (ru) 2016-08-10
JP2015520223A (ja) 2015-07-16
WO2013190496A3 (en) 2014-02-27
WO2013190496A2 (en) 2013-12-27
EP2863928A2 (en) 2015-04-29
ITMI20121076A1 (it) 2013-12-21
CN104640552A (zh) 2015-05-20

Similar Documents

Publication Publication Date Title
IL268850A (en) Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseases
MX2015009058A (es) Composiciones y metodos para tratar la inflamacion cronica y las enfermedades inflamatorias.
HUE053853T2 (hu) Szinergikus készítmények mezõgazdasági termények megvédésére, valamint ezek alkalmazása
MX2020009780A (es) Compuestos de inhibidor de autotaxina.
PH12016500866A1 (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
WO2014205389A8 (en) Nuclear transport modulators and uses thereof
IL231536A (en) Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases
MX377340B (es) Composiciones en solución sólida y uso en el tratamiento de enfermedades cardiovasculares.
IL236920B (en) Ophthalmic compositions and their use for treatment of eye diseases and disorders in animals
EA201391536A1 (ru) Противомикробные соединения и способы их получения и применения
HRP20180872T1 (hr) Životinjska hrana i postupak njezine pripreme
LT3292875T (lt) Kompozicijos ir būdai, skirti ligų gydymui
UY35652A (es) Bencil-1h-pirazolo[3,4-b]piridinas y su uso
MX2015009045A (es) Composiciones y metodos para tratar el dolor severo.
MX2018012285A (es) Metodos de tratamiento para enfermedades colestasicas y fibroticas.
NI201600070A (es) Inhibidores tetracíclicos de autotaxina
EA032271B9 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
HRP20191361T1 (hr) Pripravci ceramidaze terapeutske kiseline i postupci njihove izrade i uporabe
HUE051295T2 (hu) Módosított fibroblaszt növekedési faktorok-1 szembetegségek kezelésére
UY37671A (es) N-ariletil-2-aminoquinolin-4-carboxamidas sustituidas y su uso
EP2708551A4 (en) PEPTIDES WITH ANTIMICROBIAL ACTIVITY, THERAPEUTIC AND PROPHYLACTIC THERAPEUTIC DRUG COMPOSITIONS, COMPOSITIONS FOR THERAPEUTIC AND PROPHYLACTIC USE, USES THEREOF, AND USES OF PAENIBACILLUS EXTRACT
HRP20180345T1 (hr) Derivati sterola i njihova upotreba u liječenju bolesti koje uključuju transformirane astrocitne stanice, ili u liječenju zloćudnih hemopatija
IN2015KN00091A (cs)
EA201690574A1 (ru) Применение пидотимода в лечении заболеваний, связанных с воспалением
HK1202868A1 (en) Carboxamide-substituted heteroaryl-pyrazoles and the use thereof